Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerJLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ ActivationLong-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cellsChemoresistance of glioblastoma cancer stem cells--much more complex than expected.The interconnectedness of cancer cell signaling.Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models.The renal v-ATPase a4 subunit is expressed in specific subtypes of human gliomas.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationTriacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth.
P2860
Q24628746-415F7283-2670-4EA9-B86A-2D8FE5B72D39Q30500762-B14FC94D-B425-4DED-9495-8782F7EDAA1AQ34105361-2C9D8E89-4639-4744-996A-3216A795EDCDQ35053662-D8D3A736-26E6-47CF-B194-D8507DE07488Q35521316-B0558CD9-4B8F-4303-8553-FC2FCE8878F7Q35669733-5DBFBC66-3C7E-4B38-8B9D-B07CD958F47FQ36875981-5E2DAE12-D872-443B-985E-668C62B9697EQ38978515-9FC98AC1-B16D-4651-9AD0-E9C57CA71EEFQ39372069-39A8F942-3279-4C8A-9E0F-6ED61D33DAB9Q41879186-24B2607C-F726-4DA0-96D5-9AAA9D660B92Q42001741-D7C50246-C1A6-4053-86F7-D7BA41AA2FA7Q54237634-1C8196EB-5925-42D9-A2D8-3F7AE7BFC6A4
P2860
Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@ast
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@en
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells.
@nl
type
label
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@ast
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@en
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells.
@nl
prefLabel
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@ast
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@en
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Long-term temozolomide treatme ...... Hs683 oligodendroglioma cells
@en
P2093
Benjamin Le Calvé
Christine Decaestecker
Céline Bruyère
Delphine Lamoral-Theys
Florence Lefranc
Jacques Dubois
Marie Le Mercier
Michal A Rynkowski
Robert Kiss
P2860
P356
10.1593/NEO.91360
P577
2010-01-01T00:00:00Z